Related Experiment Video
Updated: Jan 31, 2026
06:59
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
11.4K
[Glucose metabolism in older patients]
T Laurentius1, M Freitag1,2, J Eitner1
1Lehrstuhl für Altersmedizin, Klinik für Innere Medizin und Geriatrie am Franziskushospital Aachen, Uniklinik RWTH Aachen, Morillenhang 27, 52074, Aachen, Deutschland.
Der Internist
|January 9, 2019
Summary
Age-related changes in glucose metabolism impact diabetes care for older adults. This review examines how insulin resistance, beta-cell dysfunction, and incretin secretion affect elderly patients with diabetes.
Area of Science:
- Gerontology
- Endocrinology
- Metabolic Medicine
Background:
- Current diabetes mellitus treatment guidelines for the elderly (>65 years) rely on epidemiological data and functional health assessments.
- Age-dependent changes in glucose metabolism and homeostasis are critical to understanding diabetes pathophysiology in older individuals.
Purpose of the Study:
- To review age-related alterations in metabolic pathways relevant to specialized diabetes care in the elderly.
- To discuss the clinical implications of these metabolic changes in geriatric patients.
Main Methods:
- Literature review focusing on age-related changes in glucose metabolism.
- Analysis of the interplay between metabolic alterations, sarcopenia, and antidiabetic drug therapy.
Main Results:
- Increased insulin resistance is a key factor in age-related metabolic dysfunction.
- Age-associated beta-cell dysfunction and altered incretin secretion contribute to impaired glucose homeostasis.
- These metabolic changes have significant clinical relevance for managing diabetes in the elderly.
Conclusions:
- Understanding age-related metabolic alterations is essential for optimizing diabetes management in older adults.
- Consideration of insulin resistance, beta-cell function, incretin effects, and sarcopenia is crucial for effective therapeutic strategies.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
223
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
181
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
181
00:52What is Metabolism?
131.7K
Overview
131.7K
01:02Glucose Homeostasis: Regulation of Blood Glucose
4.1K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.1K
01:27Glucose Transporters
27.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.5K